Journal article
Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery
Abstract
We have evaluated the haemostatic efficacy of plasma derived, highly purified, solvent-detergent treated factor IX concentrate (Nanotiv), to which a nanofiltration step has recently been added to improve safety with regard to parvovirus B19, hepatitis A and other nonlipid enveloped viruses. Thirteen surgical procedures, including eight orthopaedic operations, were carried out using continuous infusion of Nanotiv in 10 haemophilia B patients …
Authors
SCHULMAN S; WALLENSTEN R; WHITE B; SMITH OP
Journal
Haemophilia, Vol. 5, No. 2, pp. 96–100
Publisher
Wiley
Publication Date
March 1999
DOI
10.1046/j.1365-2516.1999.t01-1-00284.x
ISSN
1351-8216